Monthly Archives: May 2016

ANOTHER IMPORTANT HEPATITIS C THERAPY ADDED TO THE PBS

MEDIA RELEASE: 30 April 2016 Today Hepatitis ACT welcomed news of the 1 May 2016 listing of VIEKIRA PAK on the Pharmaceutical Benefits Scheme (PBS). The addition of VIEKIRA PAK to the arsenal of new generation hepatitis C therapies expands the options to treat hepatitis C genotype 1 without the use of interferon (which often […]